First-Line Anti-TNFs Keep Rheumatoid Arthritis Manageable Long-Term

(MedPage Today) — BARCELONA — Rheumatoid arthritis (RA) patients were exceedingly unlikely to develop refractory disease when their first medical therapy was a tumor necrosis factor (TNF) inhibitor, a researcher reported here.
Among patients…